May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Expression of Soluble TNF Inhibitor Gene in the Lacrimal Gland Promotes Recovery of Tear Production, Tear Stability and Reduced Immunopathology in Rabbits with Autoimmune Dacryoadenitis
M.D. Trousdale; Z. Zhu; D. Stevenson; J.E. Schechter; T. Ritter; A.K. Mircheff
Author Affiliations & Notes
  • M.D. Trousdale
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA, United States
  • Z. Zhu
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA, United States
  • D. Stevenson
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA, United States
  • J.E. Schechter
    Cell & Neurobiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
  • T. Ritter
    Institute of Medical Immunology, Humboldt University, Berlin, Germany
  • A.K. Mircheff
    Physiology & Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
  • Footnotes
    Commercial Relationships  M.D. Trousdale, None; Z. Zhu, None; D. Stevenson, None; J.E. Schechter, None; T. Ritter, None; A.K. Mircheff, None.
  • Footnotes
    Support  EY12689, EY05801, EY10550, EY03040 and grant from RPB and Allergan.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2516. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Expression of Soluble TNF Inhibitor Gene in the Lacrimal Gland Promotes Recovery of Tear Production, Tear Stability and Reduced Immunopathology in Rabbits with Autoimmune Dacryoadenitis
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      M.D. Trousdale, Z. Zhu, D. Stevenson, J.E. Schechter, T. Ritter, A.K. Mircheff; Expression of Soluble TNF Inhibitor Gene in the Lacrimal Gland Promotes Recovery of Tear Production, Tear Stability and Reduced Immunopathology in Rabbits with Autoimmune Dacryoadenitis . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2516.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: Evaluate the effect of adenovirus-mediated transfer of soluble TNF-inhibitor gene and expression of the transgene protein in rabbit lacrimal gland with induced autoimmune dacryoadenitis. Methods: Autoimmune dacryoadenitis was induced in adult female NZW rabbits by injecting peripheral blood lymphocytes (PBL), previously activated by 5 days of co-culture with autologous lacrimal acinar cells in a mixed cell reaction. Two weeks later, after tear production and tear stability started to decline, an adenoviral vector carrying the TNF-inhibitor gene (AdTNFRp55-Ig) was injected (1 X 108 pfu/gland) directly into the lacrimal gland. Tear production was monitored by Schirmer test and tears were collected for detection of TNF-inhibitor protein. Cornea surface was evaluated by determining tear breakup time and rose bengal staining. Frozen lacrimal gland sections were stained for CD4, CD8, rabbit thymic lymphocyte antigen (RTLA) and CD18 antigen expression. Results: The average Schirmer score for rabbits with autoimmune disease started at 7.6 was 4.5 after 2 weeks and 3.9 at week 4. Following gene therapy at 2 weeks, tear production returned to normal levels of 8.1 by week 4. Tear BUT dropped from 20 to 11.3 seconds between 0 and 2 weeks in the untreated group. In the treated group, tear BUT improved to 16 seconds while untreated scores continued to decline. Rose bengal scores started at 0.2 and increased to 2.6 following induction of disease. Gene therapy resulted in a reduced staining (1.6) whereas rose bengal scores in untreated animal continued to increase to 3.4. In the lacrimal gland, the CD4 to CD8 ratio in the disease group was 4:1 compared to 1:2 in the treated group. RTLA and CD18+ cells were reduced approximately 50% following gene therapy. Conclusions: Gene therapy treatment of rabbits with induced autoimmune dacryoadenitis resulted in improved basal tear production, increased tear stability and reduced rose bengal staining of the cornea.

Keywords: cornea: tears/tear film/dry eye • autoimmune disease • gene transfer/gene therapy 
© 2003, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept